Critical Care: ABX and Glucocorticoids in Sepsis Flashcards

1
Q

List two principal considerations when selecting empiric antibiotics in sepsis

A
  1. suspected location of infection

2. risk of multidrug-resistant pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List four common sources of infection in sepsis

A
  1. lung
  2. abdomen
  3. blood
  4. urinary tract
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List four risk factors that should be weighed when considering empiric fungal therapy for sepsis

A
  1. recent abdominal surgery
  2. long-term PN
  3. indwelling central venous catheters
  4. recent treatment with broad-spectrum antibiotics
  5. immunocompromised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List five immunocompromising conditions to consider in sepsis

A
  1. chronic corticosteroids
  2. immunosuppressants
  3. neutropenia
  4. malignancy
  5. organ transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List three options for empiric fungal therapy in sepsis

A
  1. triazoles, such as fluconazole
  2. echinocandin
  3. lipid formulation of amphotericin B
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List three compelling indications for using echinocandins as the antifungal in sepsis

A
  1. septic shock
  2. recently treated with antifungal agents
  3. candida glabrata or candida krusei
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List four additional considerations in select of empiric antimicrobial therapy

A
  1. history of drug allergy or intolerance
  2. recent antibiotic use
  3. comorbidities
  4. antimicrobial susceptibility patterns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Consider empiric antiviral therapy with ________ for patients presenting with ________

A
  1. oseltamivir

2. Patients presenting with flulike symptoms during flu season

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the timing of antimicrobials in relation to other procedures in the bundle

A
  1. begin IV antimicrobials as soon as possible, at least within first hour
  2. ideally after two sets of blood cultures and other potential sites of infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If several antibiotics are prescribed, then _______

A

administer the broadest coverage first and infuse as quickly as possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mortality increases by ___% for each 1-hour delay in administering appropriate antimicrobials

A

7.6%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Appropriate antimicrobials do not reduce the importance of emergency source control by these three things:

A
  1. drainage
  2. debridement
  3. device removal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List two factors when considering antimicrobial de-escalation

A

Culture data or clinical judgment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Empiric use of combination therapy should not be administered for longer than ____ days if de-escalation to a single agent is appropriate

A

3-5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Consider discontinuing antimicrobials after ____ days for most serious infections

A

7-10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List five factors that may require a longer duration of ABX for sepsis than what is standard

A
  1. slow response
  2. an undrainable foci
  3. immunologic deficiences
  4. bacteremia with S. aureus
  5. Some fungal or viral infections
17
Q

____, a serum biomarker, can be used as a guide for antibiotic therapy

A

Procalcitonin

18
Q

Describe the pros and cons of protocols that encourage or discourage the use of ABX based on certain serum biomarkers concentrations

A

(procalcitonin)

  1. Decrease unnecessary antibiotic use
  2. Without increasing harm to patients
19
Q

_____ antimicrobials if no infectious cause if found

A

discontinue

20
Q

What is the underlying biological plausibility for using corticosteroids in sepsis?

A

Adrenal function in critically ill patients can be suppressed by endotoxins produced by bacteria AND by the body’s immune response to stress

21
Q

Describe relationship between vasopressosr and glucocorticoids in sepsis

A

Early studies showed a relationship between vasopressor responsiveness and glucocorticoid administration

22
Q

How can you test a patient’s corticotropin response in sepsis? Is it recommended?

A
  1. No longer recommended

2. A corticotropin stimulation test “stim test”

23
Q

Describe how a corticotropin stimulation test is performed

A

Administering 250 mcg of cosyntropin (synthetic adrenocorticotropic hormone) and measuring cortisol concentrations at baseline, 30 minutes and 60 minutes after

24
Q

How to interpret a corticotropin stimulation test?

A
  1. A cortisol increase of 9 mcg/dL is said to be an appropriate response. (i.e. responders)
  2. Changes of less than 9 mcg/dL may indicate corticosteroid insufficiency
25
Q

Describe three reasons why corticotropin stimulation tests are not recommended in the general ICU population

A
  1. High dose of cosyntropin administered
  2. Inability to measure free (active) cortisol
  3. Lack of data on outcomes on responders vs. nonresponders
26
Q

Describe the SSC guidelines on use of corticosteroids in sepsis

A
  1. SSC recommends against using hydrocortisone to treat adults with septic shock if adequate fluid resuscitation and vasopressor therapy are able to erstore hemodynamic stability
  2. If this is not achievable, the SSC suggests intravenous hydrocortisone alone at a dose of 200 mg per day.
27
Q

What do the American College of Critical Care Medicine corticosteroid insufficiency guidelines recommend?

A
  1. Hydrocortisone should be considered in the management for patients with septic shock, particular those who have responded poorly to fluid resuscitation and vasopressor therapy.
28
Q

What do the SSC guidelines about about fludrocortisone?

A

Although fludrocortisone was a component of the treatment regimen in some studies, the SSC only includes hydrocortisone in recommendations for septic shock

29
Q

What do the American College of Critical Care Medicine say about discontinuing corticosteroid therapy?

A

Patients should be weaned off of steroid therapy once vasopressors are no longer necessary

30
Q

What do the different guidelines say about the role of corticotropin stimulation test in identifying subset of patients for corticosteroid treatment?

A
  1. SSC recommends against using the corticotropin stimulation test to identify the subset of adults with septic shock who should receive hydrocortisone.
  2. ACCM says stim test shoudl not be used to identify patients with septic shock or acute respiratory distress syndrome (ARDS) who should receive glucocorticoids.
31
Q

List four landmark trials in the use of steroids in septic shock

A
  1. A study in 2002
  2. CORTICUS (2008)
  3. ADRENAL (2018)
  4. APROCCHSS (2018)
32
Q

Describe the study in 2002 published about adult patients with septic shock and corticosteroids

A
  1. Population: Adult patients with septic shock
  2. Intervention: IV hydrocortisone + oral fludrocortisone
  3. Comparison: placebo
  4. Outcome: Steroid therapy improved 28-day survival, which was driven by the improvement by nonresponders. Responders to the stim test showed no improvement with steroids.
33
Q

Describe CORTICUS (2008)

A
  1. Population: Adult patients with septic shock
  2. Intervention: IV hydrocortisone
  3. Comparison: Placebo
  4. Outcome: Corticosteroids not associated with mortality benefit. Associated with higher risk of hyperglycemia, new sepsis or septic shock.
  5. Implication: Corticosteroids are not recommended in patients with septic shock who have been stabilized with fluid and vasopressor therapy.
34
Q

Describe ADRENAL (2018)

A
  1. Population: Adult patients with septic shock
  2. Intervention: IV hydrocortisone
  3. Comparison: Placebo
  4. Outcome: No difference in 90-day all cause mortality, but hydrocortisone had decreased duration of septic shock and blood transfusions.
  5. This is the largest randomized controlled trial assessing steroids in septic shock.
35
Q

Describe APROCCHSS (2018)

A
  1. Population: adult patients with septic shock
  2. Intervention: IV hydrocortisone + oral fludrocortisone
  3. Comparison: Placebo
  4. Outcome: Decrease in 90-day all cause mortality and duration of septic shock in patients treated with hydrocortisone and fludrocortisone
36
Q

Describe the current controversies with glucocorticoids in septic shock

A
  1. There seems to be consistency as to the short-term benefits including decreased time to resolution of shock.
  2. The mixed results from numerous studies leaves uncertainty as to the mortality benefit of steroid in septic shock.